Monaco Asset Management SAM
- SEC CIK
- 0001803593
- Latest filing
- Aug 7, 2026
DNA holding history
Ginkgo Bioworks Holdings, Inc. in every 13F filed by Monaco Asset Management SAM, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNA overviewAll 13F holders of DNAFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −125,000−100.0% | Sold out | Holders |
| Q2 2025 | 125,000 | $1.41M | 0.5% | −52,500−29.6% | Reduced | Holders |
| Q1 2025 | 177,500 | $1.01M | 0.5% | −207,164−53.9% | Reduced | Holders |
| Q4 2024 | 384,664 | $3.78M | 1.7% | +14,539+3.9% | Added | Holders |
| Q3 2024 | 370,125 | $3.02M | 1.3% | +125,125+51.1% | AddedConverted for a 1-for-40 split | Holders |
| Q2 2024 | 9,800,000 | $3.28M | 1.6% | +9,800,000 | New | Holders |